CVS Health Co. (NYSE:CVS) Shares Acquired by LGT Group Foundation

LGT Group Foundation boosted its position in CVS Health Co. (NYSE:CVS) by 2.2% during the 4th quarter, Holdings Channel reports. The fund owned 23,467 shares of the pharmacy operator’s stock after acquiring an additional 516 shares during the quarter. LGT Group Foundation’s holdings in CVS Health were worth $1,853,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in CVS. Atticus Wealth Management LLC raised its position in shares of CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after acquiring an additional 219 shares in the last quarter. Cornerstone Planning Group LLC increased its stake in CVS Health by 111.5% in the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 243 shares during the last quarter. ZRC Wealth Management LLC lifted its position in shares of CVS Health by 400.0% during the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after buying an additional 400 shares during the last quarter. Coston McIsaac & Partners boosted its holdings in shares of CVS Health by 42.6% in the 4th quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock valued at $42,000 after buying an additional 161 shares in the last quarter. Finally, Tennessee Valley Asset Management Partners purchased a new position in shares of CVS Health in the 4th quarter valued at $50,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insider Transactions at CVS Health

In related news, Director Edward J. Ludwig acquired 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The shares were acquired at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the purchase, the director now directly owns 21,630 shares in the company, valued at $1,165,424.40. The purchase was disclosed in a document filed with the SEC, which is available through this link. In other news, Director Edward J. Ludwig acquired 1,000 shares of CVS Health stock in a transaction that occurred on Thursday, May 2nd. The shares were acquired at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the purchase, the director now owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The disclosure for this sale can be found here. Insiders own 0.24% of the company’s stock.

CVS Health Trading Up 1.4 %

Shares of CVS opened at $55.90 on Friday. The company has a current ratio of 0.81, a quick ratio of 0.63 and a debt-to-equity ratio of 0.78. The firm’s 50-day moving average is $73.19 and its two-hundred day moving average is $73.37. CVS Health Co. has a twelve month low of $53.70 and a twelve month high of $83.25. The firm has a market capitalization of $70.17 billion, a P/E ratio of 9.82, a PEG ratio of 0.86 and a beta of 0.56.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.38). The company had revenue of $88.44 billion for the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.20 earnings per share. On average, research analysts predict that CVS Health Co. will post 7.03 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.76%. The ex-dividend date was Friday, April 19th. CVS Health’s payout ratio is 46.75%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. The Goldman Sachs Group reduced their target price on CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a report on Thursday. Cantor Fitzgerald lowered CVS Health from an “overweight” rating to a “neutral” rating and dropped their target price for the company from $87.00 to $58.00 in a report on Wednesday. StockNews.com lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. Truist Financial restated a “buy” rating and set a $66.00 price objective (down previously from $90.00) on shares of CVS Health in a research report on Thursday. Finally, Leerink Partnrs downgraded shares of CVS Health from an “outperform” rating to a “market perform” rating in a report on Wednesday. Eight research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $80.35.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.